These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6121196)

  • 21. Is aspirin a cause of Reye's syndrome? A case against.
    Orlowski JP; Hanhan UA; Fiallos MR
    Drug Saf; 2002; 25(4):225-31. PubMed ID: 11994026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reye's syndrome and salicylate use, by Karen M. Starko, MD, et al, Pediatrics, 1980;66:859-864; and National patterns of aspirin use and Reye syndrome reporting, United States, 1980 to 1985, by Janet B. Arrowsmith et al, Pediatrics, 1987;79:858-863.
    Kauffman RE
    Pediatrics; 1998 Jul; 102(1 Pt 2):259-62. PubMed ID: 9729163
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypercatecholaminemia in Reye's syndrome.
    Faraj BA; Caplan DB; Newman SL; Ahmann PA; Camp VM; Kutner M
    Pediatrics; 1984 Apr; 73(4):481-8. PubMed ID: 6709427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salicylate and mitochondrial injury in Reye's syndrome.
    You K
    Science; 1983 Jul; 221(4606):163-5. PubMed ID: 6857275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired oxidative metabolism of salicylate in Reye's syndrome.
    Meert KL; Kauffman RE; Deshmukh DR; Sarnaik AP
    Dev Pharmacol Ther; 1990; 15(2):57-60. PubMed ID: 2078973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aflatoxin B1; its role in the etiology of Reye's syndrome.
    Ryan NJ; Hogan GR; Hayes AW; Unger PD; Siraj MY
    Pediatrics; 1979 Jul; 64(1):71-5. PubMed ID: 450565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scientific uncertainties in the studies of salicylate use and Reye's syndrome.
    Daniels SR; Greenberg RS; Ibrahim MA
    JAMA; 1983 Mar; 249(10):1311-6. PubMed ID: 6827709
    [No Abstract]   [Full Text] [Related]  

  • 28. Fatal case of Reye's syndrome associated with H3N2 influenza virus infection and salicylate intake in a 12-year-old patient.
    Ninove L; Daniel L; Gallou J; Cougard PA; Charpentier A; Viard L; Roquelaure B; Paquis-Flucklinger V; de Lamballerie X; Zandotti C; Charrel RN
    Clin Microbiol Infect; 2011 Jan; 17(1):95-7. PubMed ID: 20167009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reye's syndrome: updated].
    Naveh Y
    Harefuah; 1984 Apr; 106(7):329-30. PubMed ID: 6745794
    [No Abstract]   [Full Text] [Related]  

  • 30. Salicylate oral gel: Reye's syndrome.
    Prescrire Int; 2010 Jun; 19(107):123. PubMed ID: 20740719
    [No Abstract]   [Full Text] [Related]  

  • 31. [Reye's syndrome in an adult following therapy with salicylates in Still's disease].
    Tumiati B; Azzalito C; Veneziani M
    Medicina (Firenze); 1989; 9(1):64-5. PubMed ID: 2739536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute liver failure and encephalopathy (Reye's syndrome?) during salicylate therapy.
    Daum F; Zucker P; Cohen MI
    Acta Paediatr Scand; 1976 Nov; 65(6):747. PubMed ID: 998231
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic and cerebral pathology findings in children with fatal salicylate intoxication: further evidence for a causal relation between salicylate and Reye's syndrome.
    Starko KM; Mullick FG
    Lancet; 1983 Feb; 1(8320):326-9. PubMed ID: 6185805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and prognosis of Reye's syndrome.
    Glasgow JF
    Arch Dis Child; 1984 Mar; 59(3):230-5. PubMed ID: 6712271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of long chain dicarboxylic acids in the serum of two patients with Reye's syndrome.
    Ng KJ; Andresen BD; Hilty MD; Bianchine JR
    J Chromatogr; 1983 Aug; 276(1):1-10. PubMed ID: 6672002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Hypophosphataemia in Reye's syndrome.
    Keating JP; Karl IE; DeVivo DC; Haymond MW
    Lancet; 1975 Jul; 2(7923):39-40. PubMed ID: 49637
    [No Abstract]   [Full Text] [Related]  

  • 37. Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye's Syndrome warning. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Apr; 68(74):18861-9. PubMed ID: 12701599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reye's syndrome and salicylates].
    Guignard JP; Gouyon JB
    Rev Med Suisse Romande; 1988 Dec; 108(12):1005-7. PubMed ID: 3222599
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin and Reye's disease: a reinterpretation.
    Andresen BD; Alexander MS; Ng KJ; Bianchine JR
    Lancet; 1982 Apr; 1(8277):903. PubMed ID: 6122113
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum uric acid as a prognostic indicator in Reye's syndrome?
    Bhuvaneswaran C; Brewster MA
    Biochem Med; 1980 Dec; 24(3):361-3. PubMed ID: 7283990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.